Comunicati.net - Comunicati pubblicati - Emilia Romagna Comunicati.net - Comunicati pubblicati - Emilia Romagna Wed, 03 Mar 2021 22:52:06 +0100 Zend_Feed_Writer 1.12.20 (http://framework.zend.com) http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/1 The Pet MRI Market To Grow Seamlessly Between 2019 to 2029 Tue, 02 Mar 2021 11:56:13 +0100 http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/692722.html http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/692722.html persistencemarketresearch persistencemarketresearch Increasing patient scans for oncology, pediatrics, soft tissue imaging, and the ability to combine tests, which cannot be done through conventional modalities are some of added advantage of PET-MRI scanners.

The global PET-MRI market was valued at ~ US $ 80 Mn  in  2018 , which is likely to see a healthy rise over the forecast period ( 2019 - 2029 ). The shift in medical imaging towards more accurate disease detection with low radiation dose per procedure have transformed the characteristics of MR Imaging with the launch of PET-MRI Scanners.

Get Going With Sample Of Pet MRI Market Report! https://www.persistencemarketresearch.co/samples/28201

Company Profiles

  • GE Healthcare
  • Siemens AG
  • Koninklijke Philips N.V.
  • United Imaging
  • Bruker
  • Mediso Ltd.
  • Aspect Imaging
  • Cubresa Inc.
  • inviscan SAS
  • MR Solutions

Increasing accuracy of MR-based attenuation correction (AC) of the PET scan, better workflow management, and reduced ionizing radiations across various clinical applications are the features of PET-MRI scanners. These are major additions to product features since the first clinical sequential PET-MRI was installed in 2011. 

PET-MRI scanners are widely used for research purpose in pre-clinical setting for drug development and radiotracer studies. Rapid surge in such studies, in turn, creates a highly conducive environment for growth of the PET-MRI scanners market.

Manufacturers Focusing on Innovative Modalities

Oncology remains the primary application of interest for researchers where tumor localization, metabolic activity, and damaged areas are analysed more frequently with the help of these images across these equipment modalities.

Another important application is Neurology where there has been lot of clinical studies ongoing for understanding the anatomy as well as the disease and implement accurate treatment planning.

For Instance; PSMR 2019, Munich, 8th Conference on PET/MR and SPECT/MR dated 15-17 April 2019 featured innovative products from manufacturers and pilot designs from researchers. The innovative TRIMAGE project was featured at this conference. It is aimed at developing a brain-dedicated PET/MR/EEG for simultaneous acquisitions focused on study of schizophrenia, brain cancer, neuroinflammation, Alzheimer, and dementia.

How About Re-Inventing The Methodical Wheel In The Pet MRI Market? Switch Over To The “Methodology” Tab! https://www.persistencemarketresearch.co/methodology/28201

Key Manufacturers Exploring New Business Models

Manufacturers are currently focusing on development of superior quality hybrid systems with imaging modalities, such as PET & MR that provide accurate assessment in detecting lesions and metastases.

Key players are mostly focused on the establishment of subsidiaries in countries where they have a limited presence for post-sales services. United Imaging recently announced its multi-year research collaboration with Washington University School of Medicine in St. Louis to revolutionize cardiovascular technology by detecting pathological changes in heart tissues.

The agreement signed by Cubresa Inc. for distribution of its PET Inserts with Worldwide Technology (S.H.) Co., Ltd. (WAD) emphasizes on collaborative actions in the PET MRI market.

The PET MRI market is currently oligopolistic in nature, dominated by a few players with first-mover advantage. The new market entrants are either dependent on key players for technology or need to develop innovative specification-oriented products in collaboration with various research institutes.

PMR Analyzes Significance of Collaboration for Sustainable Growth

The global PET MRI market is dominated by key players like GE Healthcare, Siemens AG, and Koninklijke Philips N.V. Emerging Players are concentrating more on developing new standards not only with the resolution of the image and precision, but also on the patient experience on personalized therapy.

Strategic collaborations, research collaborations, and agreements for distribution of certain products in specific regions to gain competitive advantage are considered pivotal by manufacturers.

The PET MRI market appears to be consolidated one, and with passage of time the market structure is expected to change with novel product specifications, newer equipment designs, and business models to reach remote regions.

Keeping A Tab On Key Players In The Pet MRI Market? Go To “Purchase Now” To Decipher The Competitive Analysis In Our Pet MRI Market Report! https://www.persistencemarketresearch.com/checkout/28201

Is PET MRI Space Feasible for Market Entrants?

In its attractive stage with huge potential for exponentially higher returns on investments, clinical applications in various fields like oncology, neurology, cardiology, and other verticals are expected to increase the PET MRI market size. A deep understanding of the companies, products, USPs, strategies and recent trends can help manufacturers enter and widen product portfolio and also maintain sustainable growth.

For example, United Imaging Healthcare, a Chinese manufacturer of advanced medical products covering diagnostic imaging and medical IT solutions unveiled its HD TOF PET / MR at RSNA,  2019.  Another example includes Aspect Imaging and Brightonix Imaging together showcasing the SimPET Simultaneous Preclinical PET / MRI insert at WMIC  2018 .

Report Inclusions

Persistence Market Research offers a unique perspective and actionable insights on the PET MRI landscape in its new study, presenting historical demand assessment from  2014 - 2018  and projections from  2019 - 2029  on the basis of product type (integrated, separate, PET inserts), PET imaging technology (time-of-flight, conventional), image acquisition (sequential scanners, simultaneous scanners), application (preclinical, clinical), end user (hospitals, diagnostic laboratories, research institutes, biopharmaceutical co.) and seven key regions.

About Us: -

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers 'experience by acting as the “missing” link between “customer relationships” and “business outcomes'. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address - 305 Broadway, 7th Floor New York City,
NY 10007 United States
U.S. Ph. - + 1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales  - sales@persistencemarketresearch.com
Website  - https://www.persistencemarketresearch.com

]]>
The Disposable Incontinence Products Market To Witness A Growth-Wise Disruption Between 2019 to 2029 Tue, 02 Mar 2021 11:55:51 +0100 http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/692720.html http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/692720.html persistencemarketresearch persistencemarketresearch Rise in the prevalence of kidney disorders, bladder ailments, and other nephrological injuries drive growth of the disposable incontinence products market. Availability of products to enhance quality of life in case of patients suffering from incontinence is the key factor for commercial success of the disposable incontinence products market.

The global disposable incontinence products market  surpassed a value of US $ 9 Bn in 2018 , which is set to witness healthy growth during the period of projection (2019 - 2029).  

Planning Forward? Access Sample Of Disposable Incontinence Products Market Report! https://www.persistencemarketresearch.co/samples/11518 

Company Profiles

  • Svenska Cellulosa Aktiebolaget (SCA)
  • Becton, Dickinson and Company
  • ConvaTec Inc
  • PAUL HARTMANN AG
  • Medtronic
  • Unicharm Corporation
  • Kimberly-Clark Corporation
  • B. Braun Melsungen AG
  • Medline Industries, Inc
  • Theos Medical Systems, Inc.
  • Fujian Yifa Healthcare Products Co., Ltd
  • Abena Group
  • Mega Soft (Fujian) Hygiene Products Co., Ltd
  • Fujian Hengan Group Ltd
  • Ontex

The launch of disposable pads for women and intermittent catheters has embarked on the development of novel products that continues to favor the growth of disposable incontinence products market.

Key Takeaways

  • The disposable incontinence products market is characterized as an emerging market. Demand for disposable incontinence products is expected to increase owing to rising awareness towards personal hygiene and rising geriatric population.
  • Protective incontinence garments being comfortable to use, high absorbent capacity, and odor control feature is expected to boost the demand for disposable incontinence garments.
  • Disposable adult diaper, protective underwear, disposable sheets or underpads, and beltless and belted undergarments would continue to see significant sales in Protective incontinence garments category.
  • Growing incidence of chronic kidney disease, mental disorders, diabetes, and other renal impairment diseases are factors contributing to the U.S. disposable incontinence products market growth.
  • Indwelling urinary catheters referred as “Foley” is a closed sterile device. These catheters with better usage for short durations are allowing the segment to grow during the forecast period at an expected CAGR of ~3%.
  • Superabsorbent remain the most lucrative segment in the disposable incontinence products market owing to its super absorbency and high retention quality.

How About Revitalizing The Strategy-Oriented Funnel To Stay Ahead In The Disposable Incontinence Products Market? https://www.persistencemarketresearch.co/methodology/11518

Innovation in material technology to provide maximum comfort and improved absorption capabilities in incontinence disposable products are allowing manufacturers to gain significant market share, thereby widening the growth prospects of disposable incontinence products market.

Planning To Introduce An Offbeat Product/Technology In The Disposable Incontinence Products Market? Go To “Purchase Now” To Have Our Disposable Incontinence Products Market Report! https://www.persistencemarketresearch.com/checkout/11518

Strategic Acquisition to Lend Winning Imperatives for Market Participants

The key players of disposable incontinence products are focusing on product development to increase their growth prospects. Mergers and acquisitions are the key strategies of market players to enhance geographical reach for existing and new products.

For instance, in March 2017, Ontex acquired the personal hygiene business of Hypermarcas. This acquisition helped Ontex to expand its product portfolio.

Persistence Market Research offers a unique perspective and actionable insights on disposable incontinence products in its latest study, presenting historical demand assessment from 2014 - 2018 and projections from 2019 - 2029.

The global disposable incontinence products market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on disposable incontinence products market on basis of product type (Protective incontinence garments, urine bags, urinary catheters), raw material (plastic, cotton fabrics, super absorbents, cotton fiber, latex) and distribution channel (institutional sales, retail sales) across five major regions.

About Us: -

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers 'experience by acting as the “missing” link between “customer relationships” and “business outcomes'. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address - 305 Broadway, 7th Floor New York City,
NY 10007 United States
U.S. Ph. - + 1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales  - sales@persistencemarketresearch.com
Website  - https://www.persistencemarketresearch.com

]]>
The Orally Disintegrating Tablet Market To Ruffle Healthy Feathers Between 2019 to 2029 Tue, 02 Mar 2021 11:55:28 +0100 http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/692717.html http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/692717.html persistencemarketresearch persistencemarketresearch Improvements in drug delivery mechanism offering quicker onset of action with superior bioavailability per dose have transformed characteristics of orally administered drugs with the development of orally disintegrating tablets (ODTs). The  global orally disintegrating tablets market  was valued at nearly  US $ 12 Bn  in  2018  and will exhibit a solid CAGR during the forecast period ( 2019 - 2029 ).

There has been growing preference among consumers and patients for orally disintegrating tablets attributed to increasing applications in treatment of diseases related to central nervous system (CNS), gastrointestinal (GI), cardiovascular disorders, and allergy.

Strategizing The Moves For The Next Decade? See Through Sample Of Orally Disintegrating Tablet Market Report! https://www.persistencemarketresearch.co/samples/14572

Company Profiles

  • Teva Pharmaceutical Industries Ltd.
  • Novartis AG
  • AstraZeneca
  • Mylan N.V.
  • Pfizer Inc.
  • Johnson & Johnson Services, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Merck & Co., Inc.
  • Bausch Health
  • GlaxoSmithKline plc.
  • Sun Pharmaceutical Industries Ltd.
  • Bayer AG
  • Eli Lily and Company
  • Dr. Reddy’s Laboratories Ltd.
  • Takeda Pharmaceutical Company Limited

Bayer’s acquisition of Merck’s consumer care unit was aimed at gaining shares in ODTs. Claritin, an ODT received through this acquisition, was the largest revenue generating drug for allergy in the U.S. that year.

Key Takeaways - Orally Disintegrating Tablets Market Study

  • CNS diseases remain the primary area of application for orally disintegrating tablets. Researchers and healthcare providers are increasingly focusing on medical conditions such as encephalitis, autism, Alzheimer’s disease, schizophrenia, depressive disorders and others to increase the application of orally disintegrating tablets.
  • Formulation process of orally disintegrating tablets is usually patented by manufacturers depending on the technology employed during the production such as lyophilization, freeze drying, and floss formation. Many technologies such as ZYDIS®, LYOC® and QUICKSOLV® are dependent on freeze drying method.
  • Easy disintegration of orally disintegrating tablets in saliva within a few seconds and accuracy of dose as compared to liquid forms and chewable tablet are expected to increase the adoption of ODTs in diseases such as ulcers of throat.

Starting With The New Decade On A Diligent Note In The Orally Disintegrating Tablet Market? https://www.persistencemarketresearch.co/methodology/14572

Attributed to consumers facing swallowing problems, bitter taste of drugs, and patient incompliance, manufacturers are focusing to improve drug formulations. This would help them gain an edge in terms of innovation, further favoring the growth of orally disintegrating tablets market.

Key Manufacturers Exploring New Business Models

The global orally disintegrating tablets market is fragmented with low entry barriers inspiring generic manufacturers to tap market opportunities in the form of ANDA, arising from the expiry of patent regime of approved drugs.

For instance, Mylan N.V. launched Lansoprazole DR ODT, a generic version of Takeda's Prevacid® SoluTab DR ODT. The entry of The Himalaya Drug Company LTD. and Banyan Botanicals with new herbal ODT product offerings in next few years is expected to increase product lines and extension in ODTs market.

How About Obtaining Insights About The Region To Enter Concerning The Orally Disintegrating Tablet Market? Press The “Purchase Now” Button To Have Our Orally Disintegrating Tablet Market Report! https://www.persistencemarketresearch.com/checkout/14572

Report Inclusions

Persistence Market Research offers a unique perspective and actionable insights on the Orally Disintegrating Tablets landscape in its new study, presenting historical demand assessment from  2014 - 2018  and projections from  2019 - 2029  on the basis of drug class (anti-psychotics, anti-epileptics, CNS stimulants, anxiolytics, anti-Parkinsonian drugs, anti-hypertensives, NSAIDS, anti-allergy drugs, proton pump inhibitors), disease indication (CNS diseases, GI diseases, allergy, CVS disorders), distribution channel (hospital pharmacies, retail pharmacies, drug stores, online pharmacies), and five key regions.

About Us: -

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers 'experience by acting as the “missing” link between “customer relationships” and “business outcomes'. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address - 305 Broadway, 7th Floor New York City,
NY 10007 United States
U.S. Ph. - + 1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales  - sales@persistencemarketresearch.com
Website  - https://www.persistencemarketresearch.com

]]>
The Secure Messaging In Healthcare Market To Witness A Healthy Transition Between 2019 to 2029 Tue, 02 Mar 2021 11:55:05 +0100 http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/692716.html http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/692716.html persistencemarketresearch persistencemarketresearch Secure messaging in healthcare is set to become a billion-dollar market by  2029 , as indicated by a new research report of Persistence Market Research (PMR). Witnessing stupendous expansion at a CAGR of 20%  during the forecast period ( 2019-2029 ), the market for  secure messaging in healthcare  will receive a prominent push from increasing demand for electronically secure messaging software, physician to patient secure communication, physician to physician secure e-consultation, and obligatory implementation of secure messaging in healthcare enterprises. 

Adoption of secure messaging in healthcare sectors such as hospitals, laboratories, and clinics helps in address a variety of routine health issues more effectively and efficiently. It offers different features such as remote lock & wipe, message self-destruct, and passcode protection.

Want Insights To Secure Messaging In Healthcare Market? Ask For Sample! https://www.persistencemarketresearch.co/samples/16150

Company Profiles

  • Vocera Communications, Inc.
  • Imprivata Inc.
  • Spok Inc.
  • Cerner Corporation
  • Athena Health, Inc.
  • TigerText
  • Patientsafe Solutions, Inc.
  • CellTrust Corporation
  • Voalte
  • Amtelco

The reliability of such features drive the secure messaging in healthcare market growth.

Key Takeaways - Secure Messaging in Healthcare Market Study

  • Increasing adoption of mobile application for secure messaging in healthcare organizations, is creating potential growth opportunities for secure messaging in healthcare market.
  • The technological advancement in IT systems plays an important role in the expansion of digital healthcare IT platforms. It improves clinical workflow, patient care, satisfaction, and clinical outcomes.
  • Privacy and data security issues in the healthcare industry are propelling secure messaging in healthcare market growth.
  • The research study of PMR report, component sector of the secure messaging in healthcare market is projected to generate an incremental opportunity of ~US$ 979 Mn for during the forecast period of 2019 to 2029.

Planning To Conclude Your Strategy On A Decisive Note In The Secure Messaging In Healthcare Market? Glance Through The “Methodology” Implied! https://www.persistencemarketresearch.co/methodology/16150

The demand for secure messaging in healthcare platform to manage reliable secure communication for healthcare professionals is expected to further accelerate the growth of the secure messaging in healthcare market. Technological sophistication of hospitals, clinics, and diagnostic laboratories will continue to provide further impetus to adoption.

What Does Competitive Structure Reflect?

The report provides valuable insights on the company level, focusing on the competitive scenario in the secure messaging in healthcare market along with the business and marketing strategies of the upcoming market players. Some of the market players featured in the report are Vocera Communications, Imprivata Inc., Spok Inc., Cerner Corporation, Athena Health, Inc., TigerText, PatientSafe Solutions Inc., CellTrust Corporation, Voalte, and Amtelco.

The global secure messaging in healthcare market is highly competitive due to the presence of a large number of players. Leading market participants currently hold around 50-55% of the market share.

Prominent players or healthcare organizations in the market are forming strategic partnerships for the development of new technologies and software products. For instance, in September 2019, Australian Digital Health Agency (ADHA) partnered with 42 organizations to develop a secure message functionality across various software products.

How About Knowing The Product/Technology Driving The Secure Messaging In Healthcare Market Before Investing Therein? Click The “Purchase Now” Button Of Our Secure Messaging In Healthcare Market Report! https://www.persistencemarketresearch.com/checkout/16150

Future Outlook

In the recent past, it is observed that healthcare organizations in the Asia Pacific region are deploying secure messaging platforms in order to improve patient care.

This also helps enhance the text messaging capabilities by providing secure, traceable, and HIPPA-complaint text communications between caretakers, physicians, and nurses. These factors are creating potential growth opportunity for developers and providers of secure messaging in healthcare.

Know More About Secure Messaging in Healthcare Market Report

A new market research report published by Persistence Market Research (PMR) on the global secure messaging in healthcare market includes global industry analysis for 2014–2018 and opportunity assessment for the 2019–2029. The report provides a valuable analysis of the global secure messaging in healthcare market through three different categories - component (software, services), industry (hospitals, clinics, and laboratories), and region.

About Us: -

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers 'experience by acting as the “missing” link between “customer relationships” and “business outcomes'. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address - 305 Broadway, 7th Floor New York City,
NY 10007 United States
U.S. Ph. - + 1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales  - sales@persistencemarketresearch.com
Website  - https://www.persistencemarketresearch.com

]]>
The Oncolytic Virus Immunotherapy Market To Resonate With Growth Between 2019 to 2029 Tue, 02 Mar 2021 11:54:43 +0100 http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/692715.html http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/692715.html persistencemarketresearch persistencemarketresearch The new study report by Persistence Market Research (PMR) reveals that the oncolytic virus immunotherapy market value is all set to reach  US $ ~ 67 Mn, by 2019-end . As per the PMR's report, the  oncolytic virus immunotherapy market  is estimated to grow at a CAGR of ~ 12% over the period of assessment, 2019-2029.  

Increasing adoption of adjuvant therapy in developed economies has been fueling the demand for new treatments such as oncolytic virus immunotherapy. For instance, the launch of first FDA approved oncolytic virus, IMLYGIC™ (talimogene laherparepvec) by the leading pharmaceutical manufacturer Amgen has offered oncologists and patients a wider and more targeted treatment approach for overcoming cancer. Amgen’s IMLYGIC™ remains the only FDA approved oncolytic virus immunotherapy drug that is prescribed for melanoma cancer.

Strategizing The Moves For The Next Decade? See Through Sample Of Oncolytic Virus Immunotherapy Market Report! https://www.persistencemarketresearch.co/samples/15262

Company Profiles:

  • BioVex, Inc. (Amgen, Inc.)
  • Cold Genesys, Inc.
  • DNAtrix Therapeutics
  • Genelux Corporation
  • Lokon Pharma AB
  • Oncolytics Biotech, Inc.
  • ORYX GmbH & Co. KG
  • PsiOxus Therapeutics
  • SillaJen, Inc.
  • Sorrento Therapeutics, Inc.
  • Takara Bio
  • Targovax ASA
  • Transgene sa
  • Turnstone Biologics
  • VCN Biosciences
  • Viralytics Ltd. (Merck & Co., Inc.)
  • Vyriad
  • Shanghai Sunway Biotech

Favorable reimbursement for oncolytic virus immunotherapy is poised to offer new growth opportunities for the market players. Additionally, Affordable Care Act in the U.S. is paving the way for successfully increasing insurance coverage for cancer treatment, and the result is likely to lead to increased demand for oncological therapies.

Such factor along with several favorable policies for cancer treatment is anticipated to contribute immensely towards the growth of the oncolytic virus immunotherapy industry during the forecast period.

Growing Prevalence of Metastatic Cancer Bringing in Massive Competition in the Oncolytic Virus Immunotherapy Landscape

According to PMR, growing prevalence of metastatic cancer and rising demand for adjuvant therapy drugs and cancer relapses during cancer treatment have created opportunities for key market players to come up with oncolytic virus immunotherapy products at competitive rates by combining new viruses.

Starting With The New Decade On A Diligent Note In The Oncolytic Virus Immunotherapy Market? https://www.persistencemarketresearch.co/methodology/15262

Apart from the top global market players such as BioVex, Inc. (Amgen, Inc.) and Shanghai Sunway Biotech Co. Ltd. (China), there are several other players in the regional oncolytic virus immunotherapy market that are constantly focusing on discovering new drug candidates in oncolytic virus immunotherapy.

Most of the drugs in the pipeline are in various stages of clinical trials awaiting market approvals. For example, oncolytic viruses from Transgene/Sillajen, Oncolytic Biotech and other players are in the late phase III stage of clinical trials, and are expected to enter the oncolytic virus immunotherapy market in the coming years.

According to the PMR’s report, the adoption of oncolytic virus immunotherapy in hospitals will continue to account for relatively high market share, while stakeholders are targeted towards capitalizing on specialty clinics. A significant rise in demand for oncolytic virus immunotherapy drugs in developed countries will further work to the advantage of the market players.

A remarkable shift has been observed in the new drug development and product launch in cancer treatment drugs as the blockbuster drug model is dead.

Key players are now adopting new strategies to develop adjuvant therapies and supportive therapies that can help irradiate cancer at the maximum level, such as oncolytic virus immunotherapy combined with chemotherapy. Such developmental trends are likely to remain instrumental to the growth of the oncolytic virus immunotherapy market.

How About Obtaining Insights About The Region To Enter Concerning The Oncolytic Virus Immunotherapy Market? Press The “Purchase Now” Button To Have Our Oncolytic Virus Immunotherapy Market Report! https://www.persistencemarketresearch.com/checkout/15262

Increasing Immunotherapy Research Will Offer New Growth Prospects

According to the PMR study, increasing importance of R&D in oncology medicines and immunotherapies for cancers such as colorectal, lung, multiple myeloma, prostate, and melanoma is expected to create immense growth opportunities for the oncolytic virus immunotherapy market.

Besides this, collaborations among the key players in the pharmaceutical industry, funding programs and reimbursement policies to meet the unmet diagnostic and treatment needs of the patients suffering from life-threatening diseases such as cancer are also expected to fuel the growth of the oncolytic virus immunotherapy market.

Growing interest of biopharmaceutical industries in the development of biologics for various cancers, will further expand the pipeline for the treatment of cancer. Various major players are concentrating on the research for the available treatment and development of specific oncolytic virus for cancer, which will boost the market for oncolytic virus immunotherapy during the forecast period.

Further, growing acceptance of oncolytic drugs among patient pool is also high due to treatment effectiveness of the medication. Hence, companies operating in oncolytic virus immunotherapy are expected to mostly derive profit from the development of adoptive immune viruses.

The funding for cancer research and investments in cancer therapy and oncolytic virus immunotherapy have increased, which has increased the number of personnel employed and projects undertaken. The major sources of research and development spending include governments, private funding, venture capitalists or commercial organizations.

About Us: -

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers 'experience by acting as the “missing” link between “customer relationships” and “business outcomes'. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address - 305 Broadway, 7th Floor New York City,
NY 10007 United States
U.S. Ph. - + 1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales  - sales@persistencemarketresearch.com
Website  - https://www.persistencemarketresearch.com

]]>
The Operating Tables Market To Surpass Covid-19 Cringe From 2019 to 2029 Onwards Tue, 02 Mar 2021 11:54:21 +0100 http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/692714.html http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/692714.html persistencemarketresearch persistencemarketresearch A recent research study by Persistence Market Research (PMR) reveals that the operating tables market is expected to reach a value of  ~ US $ 1.3 Bn , by the end of 2029 . The study outlines the growth trails of the  operating tables market , which is estimated to register a CAGR of ~ 3% during the forecast period of 2019-2029.   

Surgery is a fundamental element of any healthcare systems. Over the last few years, the number of surgical procedures has increased.

Want Insights To Operating Tables Market? Ask For Sample! https://www.persistencemarketresearch.co/samples/3789 

Company Profiles:

  • Hill-Rom Holdings, Inc.
  • Steris Plc.
  • Stryker Corporation
  • Getinge AB (MAQUET Holding B.V. & Co. KG.)
  • Siemens AG
  • Skytron LLC.
  • Allengers Medical Systems Limited
  • Amtai Medical Equipment, Inc.
  • Medifa-hesse GmbH & Co. KG
  • OPT Surgisystems S.R.L. (TKB Group)
  • Schaerer Medical USA Inc
  • Famed Zywiec Sp. Zo.o.
  • Lojer Oy
  • AGA Sanitaetsartikel GmbH
  • Merivaara Oy
  • Alvo Medical
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Mizuho Corporation (Mizuho OSI, Inc.)
  • Nuvo Inc
  • Brumaba GmbH & Co. KG

During the surgical process, it is required to keep patient comfortable and at a fixed position especially in those surgeries where sensitive organs are involved. The demand for operating tables increases with an increase in surgical procedures, which further fuel the market growth. The global volume of surgical need to address prevalent diseases has increased exponentially, which in turn is expected to increase the demand for operating tables.

Advanced and Hybrid Operating Tables Gaining Significant Traction

In recent years, there has been a shift from manual operating tables to advanced operating tables. Manually operated mobile operating tables are being gradually replaced by new and enhanced technologies such as hydraulic, electro-hydraulic operating tables with battery-powered systems and locking drawers, which ensure medical staff to access operating tables easily without compromising patient’s convenience.

Additionally, the development of advanced and hybrid operating tables that can auto-adjust, increases the demand and brings opportunities for companies participating in the operating tables market. Hybrid operating tables system leads to increased efficiency of the surgical process necessary during critical conditions.

Further, the development of operating tables with pressure distribution mattresses prevents unintentional injuries to the patient. Such benefits significantly contribute to the increase in demand for innovative operating tables in the market and will continue to do so in the future.

Planning To Conclude Your Strategy On A Decisive Note In The Operating Tables Market? Glance Through The “Methodology” Implied! https://www.persistencemarketresearch.co/methodology/3789

According to the PMR report, significant sales of general surgical tables will continue to influence the growth strategies, while manufacturers are focusing on increasing the production of speciality operating tables to capitalize on the ever-evolving trends such as growing popularity of robotic surgeries.

General surgical tables are expected account for major share of manufacturers’ bottom lines during the forecast period of 2019-2029. Growing availability and adoption rate of such operating tables are expected to be major factors boosting the market growth.

As compared to powered and hybrid operating tables, the non-powered variants remain highly preferred among the end users, in the view of their cost-effectiveness and higher availability. Non-powered operating tables will account for half of the total sales of operating tables during the forecast period, according to the PMR report.

How About Knowing The Product/Technology Driving The Operating Tables Market Before Investing Therein? Click The “Purchase Now” Button Of Our Operating Tables Market Report! https://www.persistencemarketresearch.com/checkout/3789

Asia Pacific and North America to Lead Market Gains

According to the PMR report, growth opportunities for operating tables' market players are picking pace in North America and Asia Pacific. This is primarily attributed to the growing number of ambulatory surgical centers in these regions.

Various healthcare organizations such as Health Maintenance Organizations (HMOs), are developing multiple specialty facilities within premises of their primary healthcare facility, thereby influencing the operating tables market to grow at a faster pace and gain large revenue share.

Moreover, Asia Pacific is experiencing an increase in investments to set up hospitals and ambulatory surgical centers. The newly set up private hospitals with major investments, have provided impetus to operating tables market.

For instance, Aster DM Healthcare, with six hospitals in Indian cities such as, Kochi, Pune, Calicut, Bangalore, and Kolhapur, expanded operations in 2015-16 and invested millions to expand their business. This presents a huge opportunities for key players in the operating tables market to gain competitive edge through deployment of advanced technologies and products differentiation.

About Us: -

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers 'experience by acting as the “missing” link between “customer relationships” and “business outcomes'. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address - 305 Broadway, 7th Floor New York City,
NY 10007 United States
U.S. Ph. - + 1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales  - sales@persistencemarketresearch.com
Website  - https://www.persistencemarketresearch.com

]]>
The Veterinary Molecular Diagnostics Market To Quell Covid-19; To Reach Expand Twofold Mon, 01 Mar 2021 14:43:42 +0100 http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/692469.html http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/692469.html persistencemarketresearch persistencemarketresearch

Rise in population has led to significant increase in the amount of meat and dairy consumption across the world. In addition, growing concerns over the consumption of healthy meat and dairy products is also soaring high. Rising concerns about veterinary health in both, livestock as well as companion animals, are also leading the veterinary molecular diagnostics market toward significant growth. In America, the American Veterinary Medical Association conducts various awareness programs, and such efforts by organizations to create awareness are boosting the growth of the veterinary molecular diagnostics market.

However, the outbreak of COVID-19 in December 2019 has led to social distancing and lockdowns in more than 100 countries across the world. This has disrupted the supply chain of the market, thereby imparting a negative impact. The impact of COVID-19 is significant, and is expected to continue to be felt on the veterinary molecular diagnostics market in 20201 as well.

Want Insights To Veterinary Molecular Diagnostics Market? Ask For Sample! https://www.persistencemarketresearch.co/samples/12874

Companies covered in Veterinary Molecular Diagnostics Market Report

  • bioMérieux SA
  • IDEXX Laboratories, Inc.
  •  Thermo Fisher Scientific Inc.
  • Qiagen N.V.
  • Neogen Corporation
  • ID.Vet
  • INDICAL BIOSCIENCE GmbH
  • Veterinary Molecular Diagnostics, Inc.

Planning To Conclude Your Strategy On A Decisive Note In The Veterinary Molecular Diagnostics Market? Glance Through The “Methodology” Implied! https://www.persistencemarketresearch.co/methodology/12874

Persistence Market Research predicts that, the global veterinary molecular diagnostics market will exhibit a CAGR of around 8% during the forecast period (2020-2030).

Key Takeaways from Veterinary Molecular Diagnostics Market Study        

  • In terms of product, PCR Kits dominate the veterinary molecular diagnostics market share, and this trend is expected to continue during the forecast period, due to reliable results and cost-effective properties of the product.
  • In terms of disease, the new castle diseases segment is expected to hold more than 25% of the veterinary molecular diagnostics market, expanding at a CAGR of 8%.
  • Based on species, the livestock segment is expected to experience maximum growth during the forecast period, due to increasing dairy farming activities in countries with high demand for dairy products.
  • By end user, veterinary hospitals represented the highest revenue share of 50% in 2019, and are expected to continue dominating the veterinary molecular diagnostics market during the forecast period as well.
  • North America generated the highest revenue share of 39.4% in 2019, due to rising adoption of pets and presence of key players in the region. Europe is the 2nd most lucrative region with a revenue share of 28.4%.
  • The outbreak of COVID-19 has had a negative impact on the overall veterinary molecular diagnostics market.

“Increasing prevalence of veterinary diseases coupled with growing acceptance of molecular diagnostic techniques is expected to boost the growth of the veterinary molecular diagnostics market over the years to come,” says a PMR analyst.

How About Knowing The Product / Technology Driving The Veterinary Molecular Diagnostics Market Before Investing Therein? Click The “Purchase Now” Button Of Our Veterinary Molecular Diagnostics Market Report! https://www.persistencemarketresearch.com/checkout/12874

Rise in Consolidation Activities by Key Players

Key manufacturers in the global veterinary molecular diagnostics market are highly focused on adopting strategies that will have a positive impact on their product portfolio and as well as enhance their presence in the veterinary molecular diagnostics market. Manufacturers are actively implementing strategies such as collaborations, mergers, partnerships, and acquisitions, which is helping them create a stronger footprint in the global market.

 

About Us: -

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers 'experience by acting as the “missing” link between “customer relationships” and “business outcomes'. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address - 305 Broadway, 7th Floor New York City,
NY 10007 United States
U.S. Ph. - + 1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales  - sales@persistencemarketresearch.com
Website  - https://www.persistencemarketresearch.com

]]>
The Skin Barriers Market To Settle At US$ 465 Million Mon, 01 Mar 2021 14:43:20 +0100 http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/692468.html http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/692468.html persistencemarketresearch persistencemarketresearch

The skin barriers market is a niche market, and is a consolidated space with many major players. The parent market for skin barriers is incontinence and ostomy. Skin barriers generally fall under accessory products offered by companies to complement healing and facilitate skin protection. The potential of the skin barriers market has not yet been fully tapped because of products being less focused on and marketed.

The ongoing COVID-19 pandemic is expected to have limited impact on the global skin barriers market. Ostomy procedures and medical diagnosis of incontinence are being postponed due to more pressing needs related to coronavirus. However, due to lockdown conditions, the online sales channel is expected to aid market growth.

Persistence Market Research estimates that the global skin barriers market is set to witness a CAGR of 4% over the forecast period (2020-2030).

Get Going With Sample Of Skin Barriers Market Report! https://www.persistencemarketresearch.co/samples/28816

Companies covered in Skin Barriers Market Report

  • ConvaTec Inc
  • Hollister Inc
  • DermaRite Industries LLC
  • 3M
  • Coloplast Corp
  • Stryker
  • Integra Lifesciences Corp
  • Smith & Nephew
  • GOJO Industries
  • Medline Industries
  • B Braun Melsungen AG
  • Sonoma Pharmaceuticals Inc
  • Welland Medical Ltd.
  • Essity

How About Re-Inventing The Methodical Wheel In The Skin Barriers Market? Switch Over To The “Methodology” Tab! https://www.persistencemarketresearch.co/methodology/28816

Key Takeaways from Skin Barriers Market Study

  • By product, skin barrier sprays are expected to be the most lucrative segment in the global skin barriers market by the end of 2030.
  • By indication, incontinence and ostomy will witness a growth of almost 1.5 times from the year 2020 to 2030.
  • The institutional sales channel is expected to hold more than 50% of market share by the end of 2030.
  • By region, North America is estimated to be the most attractive region in the global skin barriers market, expanding at a CAGR of 4.4%.
  • Countries such as China, Japan, India, and South Korea have the potential to drive future growth of the skin barriers market, owing to growing burden of incontinence and increasing awareness about the condition in these regions.

There is growing trend of homecare services such as short-term nursing services and other professional aides for the elderly to help them live independently.  Elderly are the most common group suffering from incontinence, which is a major reason of using skin barrier products.

“Advancements in incontinence products coupled with increasing e-Commerce sales during the COVID-19 pandemic will propel the growth of the global skin barriers market,” proposes a PMR analyst.

Keeping A Tab On Key Players In The Skin Barriers Market? Go To “Purchase Now” To Decipher The Competitive Analysis In Our Skin Barriers Market Report! https://www.persistencemarketresearch.com/checkout/28816   

Ease of Use, Portability, & Effectiveness Remain Key Reasons Driving Demand for Skin Barrier Sprays

Skin barrier sprays are the most lucrative segment in the global skin barriers market, with an estimated market share of almost 30% by the end of 2030. Ease of usability provided by skin barrier sprays in terms of early drying on the skin, and thereby non-transferability on garments, and non-sticky consistency, are some of the advantages provided by sprays.

What Does the Report Cover?        

Persistence Market Research offers a unique perspective and actionable insights on the skin barriers market in its latest study, presenting historical demand assessment of  2015 - 2019  and projections for  2020 - 2030 , on the basis of product (skin barrier sprays, moisture barrier creams, protective ointments, and others) indication (incontinence and ostomy, chronic wounds, pressure ulcers, skin rash & dry skin, and atopic dermatitis), and distribution channel (institutional sales [hospitals, specialty clinics, long-term care centers, and skilled nursing facilities ] and retail sales [retail pharmacies, drug stores, and online sales]), across seven key regions.

 

About Us: -

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers 'experience by acting as the “missing” link between “customer relationships” and “business outcomes'. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address - 305 Broadway, 7th Floor New York City,
NY 10007 United States
U.S. Ph. - + 1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales  - sales@persistencemarketresearch.com
Website  - https://www.persistencemarketresearch.com

]]>
The Surgical and Respiratory Masks Market To Bank On Its Armory Of Product/Service Offerings By Reaching US$ 6.7 Billion Mon, 01 Mar 2021 14:42:58 +0100 http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/692467.html http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/692467.html persistencemarketresearch persistencemarketresearch

Surgical and respiratory masks are playing a crucial role during the COVID-19 pandemic and for the prevention of other diseases too. These masks are the most effective and economic non-pharmaceutical intervention measure to curb the spread of infection, which has been made mandatory to wear in public by various governments.

Surgical masks are an inevitable requirement in hospitals, and respiratory masks provide high-end protection from pathogenic microbes and viruses, which eventually contrives toward massive demand from public and healthcare workers. Escalated production, mass procurements, recent product launches, and innovative features by key players are major factors anticipated to fuel market growth. The global surgical and respiratory masks market is expected to expand at an impressive CAGR of 8% during the forecast period of 2020 to 2030, to be valued around US$ 6.7 Bn by 2030.

Planning Forward? Access Sample Of Surgical and Respiratory Masks Market Report! https://www.persistencemarketresearch.co/samples/32047

Companies covered in Surgical And Respiratory Masks Market Report

  • 3M
  • Smith & Nephew Plc.
  • Medline Industries
  • Honeywell International Inc.
  • Inspired Medical
  • Well Lead Medial Co Ltd.
  • Medtronic Plc
  • Crosstex International
  • Cardinal Health
  • Kimberly-Clark Worldwide, Inc.
  • Alpha Pro Tech
  • Ansell Ltd.
  • Halyard Health
  • Dynarex Corporation
  • DuPont

How About Revitalizing The Strategy-Oriented Funnel To Stay Ahead In The Surgical and Respiratory Masks Market? https://www.persistencemarketresearch.co/methodology/32047

Key Takeaways from Surgical and Respiratory Masks Market Study

  • Respirators contributed for a larger revenue share than surgical masks in the global surgical and respiratory masks market in 2019, owing to their advanced filters, high adoption rate, high-end protection from viruses and toxic gases, and higher cost.
  • Reusable surgical and respiratory masks are anticipated to grab notable share in the usage segment due to their massive acceptance, cost-effectiveness, and eco-friendly nature.
  • Institutional sales held more than half of the value share of the distribution channels in the global surgical and respiratory masks market, due to preference for their quality and originality.
  • North America dominates the revenue share of the global surgical and respiratory masks market, and is expected to be more lucrative with massive demand for surgical and respiratory masks to prevent contagious respiratory diseases.
  • Global downturns, looming economy, high expenses of masks, counterfeit respirators, and scarce availability are anticipated to decelerate the growth of the global surgical and respiratory masks market.
  • The COVID-19 outbreak has rocked the growth of the global surgical and respiratory masks market, driven by massive demand for these masks for protection purposes.

“Massive demand driven by the COVID-19 pandemic and other chronic diseases, along with product launches by key players to provide advanced and safer protection are projected to propel the growth of the global surgical and respiratory masks market,” says a PMR analyst.

Planning To Introduce An Offbeat Product/Technology In The Surgical and Respiratory Masks Market? Go To “Purchase Now” To Have Our Surgical and Respiratory Masks Market Report! https://www.persistencemarketresearch.com/checkout/32047

Consolidation Activity – Imperative Strategy followed by Market Players

The global surgical and respiratory masks market is experiencing consolidation activities by manufacturers, which include collaborations, acquisitions, and partnerships. Manufacturers have deliberated focus on expanding production capacity to deliver massive number of units in lesser time. For instance, on 14 th  April 2020, 3M collaborated with Cummins to elevate the production of powered-air purifier respirators to fulfill the massive demand for respirators.

What else is in the report?

Persistence market research offers actionable insights and a unique perspective on the surgical and respiratory masks market in its latest study, presenting historical demand assessment of  2015 - 2019  and projections for  2020–2030, based on product type (surgical masks and respirators), usage (reusable and disposable), and distribution channels (institutional sales and retail sales), across seven key regions. By product type, surgical masks are further segmented into basic surgical masks, anti-fog foam surgical masks, fluid / splash resistant surgical masks and others; and respirators are further segmented into single strap masks, filter dust masks, half-face masks, full-face masks, and PAPRs. By distribution channel, institutional sales are further segmented into hospitals, ambulatory surgical centers, office-based clinics, skilled nursing facilities, diagnostic laboratories, and academic and research institutes.

 

About Us: -

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers 'experience by acting as the “missing” link between “customer relationships” and “business outcomes'. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address - 305 Broadway, 7th Floor New York City,
NY 10007 United States
U.S. Ph. - + 1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales  - sales@persistencemarketresearch.com
Website  - https://www.persistencemarketresearch.com

]]>
The Indwelling Catheters Market To Scoop Sluggishness, Reach US$ 12.7 Billion Mon, 01 Mar 2021 14:42:35 +0100 http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/692466.html http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/692466.html persistencemarketresearch persistencemarketresearch

Advancements in material used for the manufacturing of indwelling catheters plays a significant role in the success of clinical catheterization and high patient convenience. Leading industry players are developing innovative material for manufacturing indwelling catheters of superior quality, performance, and patient ease. Material properties such as high resistance to collapse, minimal trauma to lumen wall, and low accumulation and occlusion are significantly focused attributes during the development and commercialization of indwelling catheters by key industry players. In addition, technological advancements such as 3– and 4-way indwelling urinary catheters provide simultaneous systemic and distal perfusion.

Key players operating in the indwelling catheters market offer a wide range of urinary incontinence products such as long-term and short-term indwelling catheters. Increase in prevalence of surgeries in hospitals is expected to boost the demand for indwelling catheters in the global market. Demand for urinary incontinence products has increased to prevent infection spread in hospitals, home care centers, surgical centers, etc., creating an absolute opportunity for the growth of the indwelling catheters market.

PMR predicts that the global indwelling catheters market is expected to reach US$ 12.7 Bn in 2030, and is expected to exhibit a CAGR of over 6% during the forecast period (2020–2030).

How About Looking Through The Sample Of Indwelling Catheters Market Report? https://www.persistencemarketresearch.co/samples/32043

Companies covered in Indwelling Catheters Market Report

  • Teleflex Incorporated
  • Cardinal Health
  • B. Braun Melsungen AG
  • Coloplast
  • Medtronic
  • ConvaTec, Inc.
  • Sterimed Group
  • Becton, Dickinson and Company
  • McKesson Medical
  • Poiesis Medical
  • COOK Medical
  • Smiths Medical
  • Rocket Medical plc.

How About Step-By-Step Insights To Indwelling Catheters Market? Look Through The “Methodology” Employed! https://www.persistencemarketresearch.co/methodology/32043

Key Takeaways from Indwelling Catheters Market Study         

  • By product, peripheral intravenous catheters are expected to gain traction in the global indwelling catheters market during the forecast period.
  • There is extensive use of peripheral intravenous catheters in hospitals and surgical centers for intravenous therapy during or after a surgery.
  • In terms of material, the Tetrafluorethylene-hexafluoropropylene (Teflon) segment is expected to gain more than half of the market value share during the forecast period.
  • Based on packaging segment, single strip packs are expected to hold nearly one-third of the market share due to higher demand for single strip packs over kit packs.
  • As per end user, hospitals lead the segment and are expected to collectively gain more than half of market share value in the indwelling catheters market during 2020-2030.
  • North America holds the highest revenue share by region due to high rate of hospitalizations, and contributes around 1/3 of the market share, owing to rise in number of patients and higher adoption of indwelling catheters. Europe is expected to offer lucrative opportunities owing to rise in demand for indwelling catheters across hospitals, nursing homes, and surgical centres.

“Rising prevalence of urological disorders and technological advancements are expected to drive growth of the global indwelling catheters market,” says a PMR analyst.

Want To Keep A Tab On The Latest Findings In The Indwelling Catheters Market? Purchase Our Indwelling Catheters Market Report Now! https://www.persistencemarketresearch.com/checkout/32043

Innovative Product Approvals – Key Strategy Embraced by Industry Players

Development and approval of technologically-advanced indwelling catheters with multiple functionalities are focused on by specialized developers and suppliers in the indwelling catheters market to strengthen their product portfolios in this time of high competitiveness. In addition, inorganic growth strategies such as acquisitions and product in-licencing are targeted by leading players in the indwelling catheters market.

COVID-19 Pandemic to Reduce Demand for Indwelling Catheterization at Healthcare Facilities

The outbreak of the novel coronavirus is expected to hamper indwelling catheterization procedures in hospitals, ambulatory surgical centers, and clinics. This short-term considerable decline in the number of indwelling catheterization is likely to hit demand in the indwelling catheters market. This highly-transmissible respiratory disease has significantly reduced hospitalization cases and surgical procedures due to fear of infection among hospitalized patients.

For instance, in 2020, a study was conducted in Italy to understand the impact of COVID-19 on hospitalization rates for acute coronary syndrome (ACS) in Northern Italy. The study found that, hospitalization rates decreased significantly by 10-30%. This significant reduction in hospitalization and subsequent catheterization procedures are expected to hamper the growth of the indwelling catheters market during the COVID-19 crisis.

What Does the Report Cover?        

Persistence Market Research offers a unique perspective and actionable insights on the indwelling catheters market in its latest study, presenting historical demand assessment of  2015 - 2019  and projections for  2020 - 2030 , on the basis of product (indwelling urinary catheters, indwelling pleural catheters, indwelling peritoneal catheters, indwelling nephrostomy catheters, and peripheral intravenous catheters), material (latex, PVC, silicone, Tetrafluorethylene-hexafluoropropylene [Teflon], and others), packaging (single strip packs and kit packs), and end user (hospitals, ambulatory surgical centers, long-term care centers, and home care), across seven key regions.

 

About Us: -

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers 'experience by acting as the “missing” link between “customer relationships” and “business outcomes'. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address - 305 Broadway, 7th Floor New York City,
NY 10007 United States
U.S. Ph. - + 1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales  - sales@persistencemarketresearch.com
Website  - https://www.persistencemarketresearch.com

]]>
The Alginate Dressings Market To Move Away From Insipidness, Reach US$ 1.1 Billion Mon, 01 Mar 2021 14:42:13 +0100 http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/692465.html http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/692465.html persistencemarketresearch persistencemarketresearch

Wound dressing plays a crucial role in healing and management. Alginate dressings are the most preferred products to treat pressure ulcers, leg ulcers, infected surgical wounds, etc. which has led to a surge in their demand. Besides, introduction of new alginate dressing products with better functionalities by market players has also aided market growth. Increasing investments in new alginate dressing development and growing efforts for their distribution by key stakeholders are major factors expected to boost the growth of the alginate dressings market.

The global alginate dressings market is projected to be valued at US$ 1.1 Bn in 2030, and is expected to exhibit a CAGR of 3.5% during the forecast period (2020 – 2030).

Planning Forward? Access Sample Of Alginate Dressings Market Report! https://www.persistencemarketresearch.co/samples/26929

Companies covered in Alginate Dressings Market Report

  • 3M Co
  • Smith & Nephew Plc
  • ConvaTec Group Plc
  • Coloplast A/S
  • BSN medical GmbH
  • B. Braun Melsungen AG
  • Mölnlycke Health Care

How About Revitalizing The Strategy-Oriented Funnel To Stay Ahead In The Alginate Dressings Market? https://www.persistencemarketresearch.co/methodology/26929

Key Takeaways from Alginate Dressings Market Study

  • Antimicrobial alginate dressings contributed for a larger revenue share than non-antimicrobial alginate dressings in the global alginate dressings market in 2019, owing to their high preference of use for wound healing.
  • High adoption of alginate dressings for the treatment chronic wounds is expected to result in notable market share of the chronic ulcers segment in the alginate dressings market.
  • Institutional sales contributed around three-fourth of value share by distribution channel due to increasing patient preference.
  • North America captured a greater revenue share among all regions, and is expected to be the most lucrative region in the global alginate dressings market during the forecast period.
  • Reluctant adoption and high cost of products are factors expected to affect the growth of the alginate dressings market around the globe.
  • Outbreak of the COVID-19 pandemic has had a moderate impact on the overall growth of the alginate dressings market, due to its adverse effect on the global economy and healthcare industry.

Increasing prevalence of chronic and traumatic wounds and continuous focus of key market players to develop advanced wound dressing products are projected to propel the global alginate dressings market over the coming years,” says a PMR analyst.

Planning To Introduce An Offbeat Product/Technology In The Alginate Dressings Market? Go To “Purchase Now” To Have Our Alginate Dressings Market Report! https://www.persistencemarketresearch.com/checkout/26929

Consolidation Activities:Imperative Strategy for Market Players

Increase in market consolidation activities by market players, including collaborations and partnerships, are characteristics of the overall competition among global alginate dressings market players. Manufacturers are focusing on collaborations with research institutes and universities to drive research & development in advanced wound care. For instance, in July 2017, Smith & Nephew collaborated with the University of Hull to drive research in the field of advanced wound care.

What else is in the report?

Persistence market research offers actionable insights and a unique perspective on the alginate dressings market, in its latest study, presenting historical demand assessment of  2015 - 2019  and projections for 2020–2030, based on alginate dressing type (antimicrobial alginate dressings and non-antimicrobial alginate dressings), indication (chronic ulcers and non-healing surgical wounds), and distribution channel (institutional sales and retail sales), across seven key regions.

 

About Us: -

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers 'experience by acting as the “missing” link between “customer relationships” and “business outcomes'. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address - 305 Broadway, 7th Floor New York City,
NY 10007 United States
U.S. Ph. - + 1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales  - sales@persistencemarketresearch.com
Website  - https://www.persistencemarketresearch.com

]]>
The Traditional Chinese Medicine Market To Move Away From Stagnation, Reach US$ 43 Billion Mon, 01 Mar 2021 14:41:51 +0100 http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/692464.html http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/692464.html persistencemarketresearch persistencemarketresearch

Traditional Chinese medicine  is one of the oldest systems of health and wellness that has been used in China for thousands of years. Other medicines mainly focus on treating a disease. But traditional Chinese medicines aim to increase immune power and look at the entire well-being. The most common type of traditional Chinese medicines includes herbal products, acupuncture, and Tai Chi, among others.

According to a latest report published by PMR, the global traditional Chinese medicine market is expected to witness a  CAGR  of more than  5%  over the forecast period ( 2020–2030 ).

Strategizing The Moves For The Next Decade? See Through Sample Of Traditional Chinese Medicine Market Report! https://www.persistencemarketresearch.co/samples/16219

Companies covered in Traditional Chinese Medicine Market Report

  • Tongrentang
  • Zhongxin Pharmaceuticals
  • Tianjin Tasly Group
  • Yuannan Baiyao
  • Solstice Medicine Company, Inc.
  • Shanghai Sundise Traditional Chinese Medicine Co., Ltd
  • China Chinese Medicine Holding Co., Ltd.
  • Hunan goldliloo pharmaceutical Co., Ltd
  • Wanbang Pharma Group Corp.
  • Chengdu Qiankun Veterinary Pharmaceuticals Co., Ltd.
  • Pfizer Inc.
  • Eli Lilly and Company
  • Novartis AG
  • GlaxoSmithKline PLC
  • Mallinckrodt Pharmaceuticals
  • Hisamitsu Pharmaceutical Co., Inc.

Starting With The New Decade On A Diligent Note In The Traditional Chinese Medicine Market? https://www.persistencemarketresearch.co/methodology/16219

 Key Takeaways from Traditional Chinese Medicine Market Study   

  • Non-traditional Chinese medicines is the leading segment by product in the global traditional Chinese medicine market. The Autism Spectrum disorder (ASD) segment has been gaining more traction in recent years, and is expected to expand at a rate of 6.7% during the forecast period.
  • North America is the leading region in the traditional Chinese medicine market, followed by Europe.
  • East and South Asia, including China, South Korea, Japan, India, and ASEAN countries, is the fastest-growing region in the traditional Chinese medicine market, due improving medical infrastructure.
  • Tong Ren Tang, Pfizer, and Novartis AG are amongst the leading players in the global traditional Chinese medicine market. These companies invest most of their revenue in R&D, and focus on strengthening their distribution channels to maintain a leading position in the traditional Chinese medicine market space.
  • 100+ health systems are partnering with retail chains, providing physician oversights and increased patient traffic to retail clinics, and extending health system networks to new patient populations.
  • The COVID-19 pandemic is a cause for concern, which has deprioritized non-essential medical treatments. This will hurt the growth of the global traditional Chinese medicine market in the short term.

How About Obtaining Insights About The Region To Enter Concerning The Traditional Chinese Medicine Market? Press The “Purchase Now” Button To Have Our Traditional Chinese Medicine Market Report! https://www.persistencemarketresearch.com/checkout/16219

“Increasing incidence of ADHD to boost growth of global traditional Chinese medicine market,” says a PMR analyst.

Rising prevalence of ADHD is a major factor contributing to revenue growth of the traditional Chinese medicine market across the globe. The exact cause of ADHD is still unclear, although genetic influence is observed in most cases.

As per data released by the Centers for Disease Control and Prevention (CDC), approximately 6.1 million (9.4%) – 388,000 children aged 2–5 years, million children aged 6–11 years, and 3 million children aged 12–17 years – were diagnosed with ADHD in the U.S. In Spain, pooled prevalence of ADHD in a population of 361,580 representing children and adolescents was estimated at 6.8% from the last decade.

Prevalence of ADHD is rising at an alarming rate, which is expected to fuel revenue growth of ADHD therapeutics such traditional Chinese medicines, as there is no specific treatment for this disorder.

Product Innovation - Key Strategy of Traditional Chinese Medicine Market Players

Major players in the global traditional Chinese medicine market are introducing innovative products to retain their market share. A patented technology called osmotic controlled release oral delivery system (OROS) is used in Concerta, manufactured by Johnson & Johnson. It releases an initial dose of methylphenidate within the first two hours of ingestion, and when the pill passes through the stomach and gastrointestinal track, water is absorbed, resulting in internal pressure, which releases small amounts of medication as the pill passes through gut. This technology was implemented to maintain consistency of improvement in cognitive performance throughout the day.

 

About Us: -

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers 'experience by acting as the “missing” link between “customer relationships” and “business outcomes'. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address - 305 Broadway, 7th Floor New York City,
NY 10007 United States
U.S. Ph. - + 1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales  - sales@persistencemarketresearch.com
Website  - https://www.persistencemarketresearch.com

]]>
The E Prescribing Market To Scoop Sluggishness, Reach US$ 887.8 Million Fri, 26 Feb 2021 15:18:22 +0100 http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/692104.html http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/692104.html persistencemarketresearch persistencemarketresearch According to a new market report published by Persistence Market Research "Global Market Study on E-Prescribing: North America to Witness Highest Growth by 2019," the global E-Prescribing market was valued at USD 250.2 million in 2013 and is expected to grow at a CAGR of 23.5% from 2013 to 2019, to reach an estimated value of USD 887.8 million in 2019.

Electronic prescribing or E-Prescribing (e-Rx) is electronic transmission of prescriptions from physician to pharmacists using computer and other mobile devices, such as cell phone and tablets. The global E-Prescribing market is witnessing a significant growth led by various government programs to implement E-Prescribing systems in order to improve quality of healthcare and reduce medication errors.

Strategizing The Moves For The Next Decade? See Through Sample Of E Prescribing Market Report! https://www.persistencemarketresearch.co/samples/3087

Some of the major players operating in the E-Prescribing market:

  • Henry Schein, Inc.
  • Cerner Corporation.
  • Allscripts.
  • eClinicalWorks.
  • DrFirst.
  • Practice Fusion, Inc.
  • Surescripts.
  • HealthFusion, Inc.
  • Emdeon.
  • athenahealth, Inc.

Starting With The New Decade On A Diligent Note In The E Prescribing Market? https://www.persistencemarketresearch.co/methodology/3087

E-Prescribing systems are used in various applications including preparation of complete medication list, data security checks, complete information of formulary and patient historical data. These advanced features of E-Prescribing are also supporting in growth of E-Prescribing market. Additionally, improved healthcare infrastructure has increased the demand for E-Prescribing system.

Moreover, implementation of electronic healthcare records with E-Prescribing system holds immense potential for the growth of E-Prescribing market. E-Prescribing market is expected to grow a CAGR of about 23.5% during 2013-2019.

However, high cost of E-Prescribing system and lack of patient privacy and security impede growth of E-Prescribing market. Moreover, lack of high-speed broadband facilities and IT professionals in rural areas are also some of the key restraints for the E-Prescribing market.

Europe holds the largest share in E-Prescribing market. Many eHealth projects in Europe are playing a vital role in the adoption of E-Prescribing system such as European Patient Smart Open Services (epSOS) and Schleswig-Holstein Health Initiative.

How About Obtaining Insights About The Region To Enter Concerning The E Prescribing Market? Press The “Purchase Now” Button To Have Our E Prescribing Market Report! https://www.persistencemarketresearch.com/checkout/3087

However, North America is the fastest growing region in the E-Prescribing market. Increased adoption of E-Prescribing system and improved healthcare infrastructure are major drivers for E-Prescribing market in North America. Moreover, several government initiatives are also promoting the usage of E-Prescribing system such as Health Information Technology for Economic and Clinical Health (HITECH) Act and National Council for Prescription Drugs Program.

In Asia, usage of E-Prescribing system is increasing due to medical infrastructure development and government initiative programs. Growing medical infrastructure has led to improvement in primary healthcare services, village clinics and urban healthcare centers through the adoption of healthcare IT technologies.

About Us: -

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers 'experience by acting as the “missing” link between “customer relationships” and “business outcomes'. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address - 305 Broadway, 7th Floor New York City,
NY 10007 United States
U.S. Ph. - + 1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales  - sales@persistencemarketresearch.com
Website  - https://www.persistencemarketresearch.com

]]>
The Osteoporosis Drugs Market To Bank On Its Armory Of Product/Service Offerings By Reaching US$14,786.7 Million Fri, 26 Feb 2021 15:18:00 +0100 http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/692103.html http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/692103.html persistencemarketresearch persistencemarketresearch According to a new market report published by Persistence Market Research "Global Market Study on  Osteoporosis Drugs : AsiaPacific to Witness Highest Growth by 2022", the global osteoporosis drugs market is estimated to be valued at US $ 11,226.1 Mn by the end of 2015 and is expected to expand at a CAGR of 4.0% from 2014 to 2022, to account for US $ 14,786.7 Mn by 2022.      

The global osteoporosis drugs market is witnessing significant growth due to rising geriatric population and changing lifestyles impinging bone health. Prevalence of osteoporosis is high among people aged 60 years and above. Moreover, increasing the prevalence of osteoporosis in postmenopausal women, growing awareness about osteoporotic care, and increasing investment in drug discovery and development are also driving the growth of the market.

Strategizing The Moves For The Next Decade? See Through Sample Of Osteoporosis Drugs Market Report! https://www.persistencemarketresearch.co/samples/2983

Top companies profiled in this report are:

  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • Merck & Co, Inc.
  • Novartis AG
  • Amgen, Inc.
  • Novo Nordisk A/S
  • Actavis plc
  • Pfizer, Inc.
  • GlaxoSmithKline plc
  • Teva Pharmaceutical Industries Ltd

Starting With The New Decade On A Diligent Note In The Osteoporosis Drugs Market? https://www.persistencemarketresearch.co/methodology/2983

However, there are various side effects and complications associated with osteoporosis drugs such as heartburn, irritable bowel syndrome, nausea, and ulcers in the stomach or esophagus. Furthermore, patent expiration of osteoporosis drugs also inhibits the growth of the market.The osteoporosis drugs market is anticipated to grow from an estimated US$11,226.1 Mn by the end of 2015 to account for US$14,786.7 Mn by 2022 at a CAGR of 4.0% during the forecast period.

In North America, the prevalence of osteoporosis is high primarily due to increasing geriatric population, growing obesity, and rising prevalence of lifestyle associated diseases in the region. According to the National Osteoporosis Foundation, in 2013, approximately 54 million people in the U.S. aged 50 years and above were affected by osteoporosis and low bone mass. According to the U.S. Department of Health and Human Services, in the U.S., approximately 250,000 hip fractures are associated with osteoporosis.

In Europe, increasing aging population, changing lifestyles, and increasing consumer awareness about osteoporosis care are driving the growth of the osteoporosis drug market. According to the International Osteoporosis Foundation, approximately 5.5 million men and 22 million women suffered from osteoporosis in 2010. Moreover, according to International Osteoporosis Foundation, approximately 27.5 million people in Europe suffered from osteoporosis in 2010 and the number is expected to reach 33.9 Mn by 2030.

How About Obtaining Insights About The Region To Enter Concerning The Osteoporosis Drugs Market? Press The “Purchase Now” Button To Have Our Osteoporosis Drugs Market Report! https://www.persistencemarketresearch.com/checkout/2983

However, the growth of osteoporosis market in Asia Pacific is much due to rising geriatric population and changing lifestyles in the region. Osteoporotic patients have a higher risk of hip fractures, owing to a major cause of morbidity and mortality.

According to the International Osteoporosis Foundation, by 2050, approximately 50% of the world's osteoporosis hip fractures would occur in women in Asia. In addition, according to a study on Epidemiology in Osteoporosis in Japan by the National Center for Biotechnology Information, in 2011, approximately 15 million people suffered from osteoporosis in Japan.

About Us: -

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers 'experience by acting as the “missing” link between “customer relationships” and “business outcomes'. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address - 305 Broadway, 7th Floor New York City,
NY 10007 United States
U.S. Ph. - + 1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales  - sales@persistencemarketresearch.com
Website  - https://www.persistencemarketresearch.com

]]>
The E Prescribing Market To Scoop Sluggishness, Reach US$ 887.8 Million Fri, 26 Feb 2021 15:17:37 +0100 http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/692102.html http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/692102.html persistencemarketresearch persistencemarketresearch According to a new market report published by Persistence Market Research "Global Market Study on E-Prescribing: North America to Witness Highest Growth by 2019," the global E-Prescribing market was valued at USD 250.2 million in 2013 and is expected to grow at a CAGR of 23.5% from 2013 to 2019, to reach an estimated value of USD 887.8 million in 2019.

Electronic prescribing or E-Prescribing (e-Rx) is electronic transmission of prescriptions from physician to pharmacists using computer and other mobile devices, such as cell phone and tablets. The global E-Prescribing market is witnessing a significant growth led by various government programs to implement E-Prescribing systems in order to improve quality of healthcare and reduce medication errors.

Strategizing The Moves For The Next Decade? See Through Sample Of E Prescribing Market Report! https://www.persistencemarketresearch.co/samples/3087

Some of the major players operating in the E-Prescribing market:

  • Henry Schein, Inc.
  • Cerner Corporation.
  • Allscripts.
  • eClinicalWorks.
  • DrFirst.
  • Practice Fusion, Inc.
  • Surescripts.
  • HealthFusion, Inc.
  • Emdeon.
  • athenahealth, Inc.

Starting With The New Decade On A Diligent Note In The E Prescribing Market? https://www.persistencemarketresearch.co/methodology/3087

E-Prescribing systems are used in various applications including preparation of complete medication list, data security checks, complete information of formulary and patient historical data. These advanced features of E-Prescribing are also supporting in growth of E-Prescribing market. Additionally, improved healthcare infrastructure has increased the demand for E-Prescribing system.

Moreover, implementation of electronic healthcare records with E-Prescribing system holds immense potential for the growth of E-Prescribing market. E-Prescribing market is expected to grow a CAGR of about 23.5% during 2013-2019.

However, high cost of E-Prescribing system and lack of patient privacy and security impede growth of E-Prescribing market. Moreover, lack of high-speed broadband facilities and IT professionals in rural areas are also some of the key restraints for the E-Prescribing market.

Europe holds the largest share in E-Prescribing market. Many eHealth projects in Europe are playing a vital role in the adoption of E-Prescribing system such as European Patient Smart Open Services (epSOS) and Schleswig-Holstein Health Initiative.

How About Obtaining Insights About The Region To Enter Concerning The E Prescribing Market? Press The “Purchase Now” Button To Have Our E Prescribing Market Report! https://www.persistencemarketresearch.com/checkout/3087

However, North America is the fastest growing region in the E-Prescribing market. Increased adoption of E-Prescribing system and improved healthcare infrastructure are major drivers for E-Prescribing market in North America. Moreover, several government initiatives are also promoting the usage of E-Prescribing system such as Health Information Technology for Economic and Clinical Health (HITECH) Act and National Council for Prescription Drugs Program.

In Asia, usage of E-Prescribing system is increasing due to medical infrastructure development and government initiative programs. Growing medical infrastructure has led to improvement in primary healthcare services, village clinics and urban healthcare centers through the adoption of healthcare IT technologies.

About Us: -

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers 'experience by acting as the “missing” link between “customer relationships” and “business outcomes'. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address - 305 Broadway, 7th Floor New York City,
NY 10007 United States
U.S. Ph. - + 1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales  - sales@persistencemarketresearch.com
Website  - https://www.persistencemarketresearch.com

]]>
The Medical Imaging Equipment Market To Quell Covid-19; To Reach US$ 45.3 Billion Fri, 26 Feb 2021 15:16:33 +0100 http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/692101.html http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/692101.html persistencemarketresearch persistencemarketresearch According to a new market report published by Persistence Market Research “Global Market Study on Medical Imaging Equipment,” the global medical imaging equipment market was valued at  US $ 29.4 Bn in 2015  and is expected to reach US $ 45.3 Bn by 2023 , growing at a CAGR of 5.6% during the forecast period from 2015 to 2023.   

Improvement in health care reforms in major countries such as Japan, the U.S., China, and U.K. has enhanced access to various diagnostic and treatment services thereby increasing life expectancy of the population. Rise in geriatric population is expected to intensify the need for healthcare products and services in these countries. Moreover, the rising incidence of diseases across the globe continue to increase the demand for diagnosis equipment, particularly non-invasive imaging solutions.

Want Insights To Medical Imaging Equipment Market? Ask For Sample! https://www.persistencemarketresearch.co/samples/11215

Key participants in global imaging equipment market include, 

  • GE Healthcare,
  • Shimadzu Corporation,
  • Philips Healthcare,
  • Genesis Medical Imaging inc.,
  • Hologic Inc.,
  • Siemens Healthcare,
  • Samsung Medison Co. Ltd,
  • Carestream Health Inc.,
  • Hitachi Medical Corporation,
  • Fujifilm Holdings Corporation,
  • Toshiba Corporation and Fonar Corporation,

Planning To Conclude Your Strategy On A Decisive Note In The Medical Imaging Equipment Market? Glance Through The “Methodology” Implied! https://www.persistencemarketresearch.co/methodology/11215

According to the World Health Organization (WHO), an estimated 17.5 Mn people died due to cardiovascular diseases in 2012, accounting for approximately 31% of global deaths. Moreover, 235 Mn people were diagnosed with asthma across the world in 2014.

On account of all these factors, the global medical imaging equipment market is expected to grow at a CAGR of 5.6% during the forecast period from 2015 to 2023. The market is driven by the major developed economies of the U.S., Europe, and Asia Pacific. However, emerging markets, particularly, China, India and Brazil are expected to be the fastest growing market in terms of CAGR during the forecast period.

With a share of more than 30% in 2015, North America was the largest market for medical imaging equipment primarily due to high awareness about medical imaging devices financial capability to purchase expensive machines, rising demand for technologically advanced and innovative products in hospitals, diagnostics laboratories and outpatient ambulatory surgery centers, and high investment in improving healthcare infrastructure.

Obesity is one of the major causes of several diseases of cardiovascular system that has led to increase in demand for diagnostic imaging in the U.S. According to the Centers for Disease Control and Prevention (CDC), the percentage of obese children aged between 6 years and 11 years increased from 7% in 1980 to 18% in 2012 in the U.S. In addition, increasing healthcare expenditure in the U.S. in recent years has also assisted in dramatic rise in the usage of medical imaging.

How About Knowing The Product/Technology Driving The Medical Imaging Equipment Market Before Investing Therein? Click The “Purchase Now” Button Of Our Medical Imaging Equipment Market Report! https://www.persistencemarketresearch.com/checkout/11215

Emerging economies such as China, India, Indonesia, Malaysia, Singapore and Thailand are providing much needed boost to the medical imaging equipment market. The Asia Pacific market is driven by demand for refurbished imaging systems as more equipment are needed with less funds dedicated to healthcare budgets. However, demand for new devices that offer superior imaging, speed, flexibility and portability are also being adopted in China and India, countries with the largest market potential.

Europe was ranked third, in terms of market size, after North America and Asia Pacific. Demand in the region is similar to North America, wherein demand for advanced equipment for all modalities is higher. Western Europe, which includes major economies such as Germany, U.K., France, and Italy, holds a major share in the region.

Others markets on the global map include Latin America and Middle East & Africa. As the markets in the developed world are becoming saturated, most the market players are focusing on emerging markets in Brazil and member states of Gulf Cooperation Council. Looking at the proximity of Brazil to the US, major market players find it convenient to have manufacturing facilities in Brazil.

Therefore, the Latin America market is poised to grow rapidly. In addition, the government efforts in GCC member states to invest in improving the healthcare infrastructure and promote medical tourism are facilitating the demand for newer medical imaging equipment.

About Us: -

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers 'experience by acting as the “missing” link between “customer relationships” and “business outcomes'. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address - 305 Broadway, 7th Floor New York City,
NY 10007 United States
U.S. Ph. - + 1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales  - sales@persistencemarketresearch.com
Website  - https://www.persistencemarketresearch.com

]]>
The Hemodynamic Monitoring System Market To Settle At US$ 508.4 Million Fri, 26 Feb 2021 15:16:11 +0100 http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/692100.html http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/692100.html persistencemarketresearch persistencemarketresearch Persistence Market Research (PMR), in a recent report, "Global Market Study on  Hemodynamic Monitoring System: Growing Demand for Critical Congenital Heart Disease Screening to Drive the Market  by 2021", projected the hemodynamic monitoring systems market to expand at a healthy CAGR of 6.5% during the forecast period. The report offered trends driving the market and delivered analysis and insights on the potential of the hemodynamic monitoring systems market in specific regions.  

In terms of revenue, the hemodynamic monitoring systems market was valued at US$ 328.7 Mn in 2014 and is projected to reach US$ 508.4 Mn by 2021. Factors driving market growth include government and private sector initiatives to reduce healthcare costs, rising prevalence of lifestyle diseases, growing the geriatric patient population, increasing the incidence of respiratory disorders and growing demand for the screening of critical congenital heart disease (CCHD).

How About Looking Through The Sample Of Hemodynamic Monitoring System Market Report? https://www.persistencemarketresearch.co/samples/4396

Competition Landscape

  • Edwards Lifesciences Corporation.
  • Argon Medical Inc.
  • Deltex Medical Group plc.
  • ICU Medical, Inc.
  • LiDCO Group Plc.
  • PULSION Medical Systems SE.
  • Nihon Kohden Corporation.
  • Teleflex Incorporated.
  • Cheetah Medical, Inc.
  • Osypka Medical GmbH.

How About Step-By-Step Insights To Hemodynamic Monitoring System Market? Look Through The “Methodology” Employed! https://www.persistencemarketresearch.co/methodology/4396

In terms of region, North America dominated the hemodynamic monitoring systems market with over 30% share in terms of value in 2014 but is expected to lose its market share to APAC by 2021. Europe accounted for over 20% of the total hemodynamic monitoring systems market share in 2014 and will maintain its dominance through 2021.

Among the regions, APAC is projected to register the highest CAGR over 2015–2021 due to low-cost product offerings by manufacturers in the region. As of 2014, APAC was the third-highest contributor to the overall hemodynamic monitoring systems market, accounting for over 18% market share. By the end of 2021, it is projected to gain 330 BPS.

On the basis of device type, the market has been segmented into pulse contour, oesophageal Doppler, volume clamp, hemodynamic monitoring sensors and pulmonary artery catheters.

The pulmonary artery catheters segment had a dominant share in the global hemodynamic monitoring systems market in 2014, while the volume clamp segment accounted for over 20% share.

Global hemodynamic monitoring systems market is further segmented on the basis of end use into hospitals, clinics, ambulatory surgery centres, home care settings and independent catheterisation laboratories. Revenue contribution of the hospitals segment was over 40% in 2014 and is projected to increase to over 42% by 2021, registering a significant CAGR of 7.3%. Home care settings segment is anticipated to record highest CAGR during the forecast period as hemodynamic monitoring systems are being adopted increasingly in home care settings.

By application type, the hemodynamic monitoring systems market is segmented into invasive hemodynamic monitoring, noninvasive hemodynamic monitoring and minimally invasive hemodynamic monitoring segments. Among the three segments, minimally invasive hemodynamic monitoring segment is expected to register the highest CAGR of 8.0% over 2015-2021. The invasive hemodynamic monitoring segment accounted for over 30% market share in 2014 but is projected to lose its share to the other two segments by the end of the forecast period.

Want To Keep A Tab On The Latest Findings In The Hemodynamic Monitoring System Market? Purchase Our Hemodynamic Monitoring System Market Report Now! https://www.persistencemarketresearch.com/checkout/4396

Browse the full Global Market Study on Hemodynamic Monitoring System: Growing demand for Critical Congenital Heart Disease screening to drive the market for Hemodynamic Monitoring Systems during the forecast period report at https://www.persistencemarketresearch.co/market-research/hemodynamic-monitoring -system-market.asp

Key players in the global hemodynamic monitoring systems market include Edwards Lifesciences Corporation, ICU Medical, Inc., Teleflex Incorporated, LiDCO Group Plc and PULSION Medical Systems SE. Global players focus on research and development initiatives for introducing innovative products to attain sustainable advantages over their competitors.

In addition, they also focus on expanding their regional presence through mergers and acquisitions. In developed regions, hemodynamic monitoring systems manufacturers prefer selling their products directly to the consumer. By contrast, most vendors in countries such as China have tie-ups with suppliers to enhance their customer reach. Globally, medical equipment manufacturers in China account for over 50% market share for exporting noninvasive devices.

About Us: -

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers 'experience by acting as the “missing” link between “customer relationships” and “business outcomes'. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address - 305 Broadway, 7th Floor New York City,
NY 10007 United States
U.S. Ph. - + 1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales  - sales@persistencemarketresearch.com
Website  - https://www.persistencemarketresearch.com

]]>
The Osteoporosis Drugs Market To Bank On Its Armory Of Product/Service Offerings By Reaching US$14,786.7 Million Fri, 26 Feb 2021 15:15:49 +0100 http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/692099.html http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/692099.html persistencemarketresearch persistencemarketresearch According to a new market report published by Persistence Market Research "Global Market Study on  Osteoporosis Drugs : AsiaPacific to Witness Highest Growth by 2022", the global osteoporosis drugs market is estimated to be valued at US $ 11,226.1 Mn by the end of 2015 and is expected to expand at a CAGR of 4.0% from 2014 to 2022, to account for US $ 14,786.7 Mn by 2022.      

The global osteoporosis drugs market is witnessing significant growth due to rising geriatric population and changing lifestyles impinging bone health. Prevalence of osteoporosis is high among people aged 60 years and above. Moreover, increasing the prevalence of osteoporosis in postmenopausal women, growing awareness about osteoporotic care, and increasing investment in drug discovery and development are also driving the growth of the market.

Strategizing The Moves For The Next Decade? See Through Sample Of Osteoporosis Drugs Market Report! https://www.persistencemarketresearch.co/samples/2983

Top companies profiled in this report are:

  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • Merck & Co, Inc.
  • Novartis AG
  • Amgen, Inc.
  • Novo Nordisk A/S
  • Actavis plc
  • Pfizer, Inc.
  • GlaxoSmithKline plc
  • Teva Pharmaceutical Industries Ltd

Starting With The New Decade On A Diligent Note In The Osteoporosis Drugs Market? https://www.persistencemarketresearch.co/methodology/2983

However, there are various side effects and complications associated with osteoporosis drugs such as heartburn, irritable bowel syndrome, nausea, and ulcers in the stomach or esophagus. Furthermore, patent expiration of osteoporosis drugs also inhibits the growth of the market.The osteoporosis drugs market is anticipated to grow from an estimated US$11,226.1 Mn by the end of 2015 to account for US$14,786.7 Mn by 2022 at a CAGR of 4.0% during the forecast period.

In North America, the prevalence of osteoporosis is high primarily due to increasing geriatric population, growing obesity, and rising prevalence of lifestyle associated diseases in the region. According to the National Osteoporosis Foundation, in 2013, approximately 54 million people in the U.S. aged 50 years and above were affected by osteoporosis and low bone mass. According to the U.S. Department of Health and Human Services, in the U.S., approximately 250,000 hip fractures are associated with osteoporosis.

In Europe, increasing aging population, changing lifestyles, and increasing consumer awareness about osteoporosis care are driving the growth of the osteoporosis drug market. According to the International Osteoporosis Foundation, approximately 5.5 million men and 22 million women suffered from osteoporosis in 2010. Moreover, according to International Osteoporosis Foundation, approximately 27.5 million people in Europe suffered from osteoporosis in 2010 and the number is expected to reach 33.9 Mn by 2030.

How About Obtaining Insights About The Region To Enter Concerning The Osteoporosis Drugs Market? Press The “Purchase Now” Button To Have Our Osteoporosis Drugs Market Report! https://www.persistencemarketresearch.com/checkout/2983

However, the growth of osteoporosis market in Asia Pacific is much due to rising geriatric population and changing lifestyles in the region. Osteoporotic patients have a higher risk of hip fractures, owing to a major cause of morbidity and mortality.

According to the International Osteoporosis Foundation, by 2050, approximately 50% of the world's osteoporosis hip fractures would occur in women in Asia. In addition, according to a study on Epidemiology in Osteoporosis in Japan by the National Center for Biotechnology Information, in 2011, approximately 15 million people suffered from osteoporosis in Japan.

About Us: -

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers 'experience by acting as the “missing” link between “customer relationships” and “business outcomes'. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address - 305 Broadway, 7th Floor New York City,
NY 10007 United States
U.S. Ph. - + 1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales  - sales@persistencemarketresearch.com
Website  - https://www.persistencemarketresearch.com

]]>
The Nano Healthcare Technology For Medical Equipment Market To Move Away From Insipidness, Reach US$ 9.2 Billion Fri, 26 Feb 2021 15:15:26 +0100 http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/692097.html http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/692097.html persistencemarketresearch persistencemarketresearch Nanotechnology is expected to potentially transform healthcare industry, especially in the medical devices field in the coming years. The global market for Nano healthcare technology for medical equipment has been witnessing a rising growth path since 2012.

Till 2016, this market has seen gradual growth, however, during the 2017-2022 period this market is expected to witness a robust growth rate.

Want Insights To Nano Healthcare Technology For Medical Equipment Market? Ask For Sample! https://www.persistencemarketresearch.co/samples/18898 

Company Profiles

  • 3M Company
  • Abbott Laboratories
  • AstraZeneca
  • Ferro Corp.
  • GE Global Research
  • Merck KGaA
  • PerkinElmer, Inc.
  • Smith & Nephew plc
  • Stryker Corporation
  • Thermo Fisher Scientific

Planning To Conclude Your Strategy On A Decisive Note In The Nano Healthcare Technology For Medical Equipment Market? Glance Through The “Methodology” Implied! https://www.persistencemarketresearch.co/methodology/18898

There are many factors which drive this meteoric growth of the entire market. The rise in aging population, rising prevalence of cardiovascular diseases, increasing incidence of diseases linked with ear, bone, and other internal organs of the body, medical advancements due to adoption of improved technology and increase in the expenditure on research in the Nanotechnology field coupled with rising government support have spurred the development of the global market for Nano healthcare technology for medical equipment.

However, certain pulling aspects such as higher initial costs and time consuming approvals for product launches are posing challenges to the advancement of the market from a global standpoint.

An exhaustive research report on “Nano Healthcare Technology for Medical Equipment Market: Global Industry Analysis (2012-2016) and Forecast (2017-2022)” skilfully crafted by Persistence Market Research focuses on various facets of the global market based on which guidelines can be slated with a view to achieve an edge over the competition as well as stability even in the unstable market conditions.

According to this research report, the global market Nano healthcare technology for medical equipment is expected to expand at a robust CAGR of 9.6% during the period of forecast 2017-2022.

How About Knowing The Product/Technology Driving The Nano Healthcare Technology For Medical Equipment Market Before Investing Therein? Click The “Purchase Now” Button Of Our Nano Healthcare Technology For Medical Equipment Market Report! https://www.persistencemarketresearch.com/checkout/18898

4 Key Insights on Global Nano Healthcare Technology for Medical Equipment Market

North America region is expected to witness high market share by 2022 end. This region lead the global market in 2016 and this trend is poised to continue over the forecast period. North America region is the largest and highly lucrative region for the growth of the global market for Nano healthcare technology for medical equipment and is expected to register the highest CAGR of 10% during the period of forecast

Asia-Pacific excluding Japan (APEJ) region is expected to show high potential after North America and is the second fastest growing region. Nano healthcare technology for medical equipment in APEJ market is expected to expand at a high 9.8% CAGR during 20170-2022. Europe, in terms of value is the second largest region owing to development in the healthcare system combined with increasing number medical device manufacturers adopting Nanotechnology in medical equipment and various programs for development of nanotechnology started by government

Implantable material and biochips segments by product type show promising growth in the coming years. Biochips segment is expected to rise at a high CAGR of 9.6% during the period of forecast. The implantable materials segment show higher market share comparatively. The active implantable devices segment is the fastest growing segment dominating the global market by product type  

Therapeutic applications segment by application type is expected to grow at a higher pace to register a  CAGR of 9.9%  during the period of forecast. In 2017, this segment portrayed higher market share and is highly likely to cement its dominance during the forecast period in terms of market share and valuation

About Us: -

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers 'experience by acting as the “missing” link between “customer relationships” and “business outcomes'. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address - 305 Broadway, 7th Floor New York City,
NY 10007 United States
U.S. Ph. - + 1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales  - sales@persistencemarketresearch.com
Website  - https://www.persistencemarketresearch.com

]]>
The E Prescribing Market To Scoop Sluggishness, Reach US$ 887.8 Million Fri, 26 Feb 2021 15:15:04 +0100 http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/692096.html http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/692096.html persistencemarketresearch persistencemarketresearch According to a new market report published by Persistence Market Research "Global Market Study on E-Prescribing: North America to Witness Highest Growth by 2019," the global E-Prescribing market was valued at USD 250.2 million in 2013 and is expected to grow at a CAGR of 23.5% from 2013 to 2019, to reach an estimated value of USD 887.8 million in 2019.

Electronic prescribing or E-Prescribing (e-Rx) is electronic transmission of prescriptions from physician to pharmacists using computer and other mobile devices, such as cell phone and tablets. The global E-Prescribing market is witnessing a significant growth led by various government programs to implement E-Prescribing systems in order to improve quality of healthcare and reduce medication errors.

Strategizing The Moves For The Next Decade? See Through Sample Of E Prescribing Market Report! https://www.persistencemarketresearch.co/samples/3087

Some of the major players operating in the E-Prescribing market:

  • Henry Schein, Inc.
  • Cerner Corporation.
  • Allscripts.
  • eClinicalWorks.
  • DrFirst.
  • Practice Fusion, Inc.
  • Surescripts.
  • HealthFusion, Inc.
  • Emdeon.
  • athenahealth, Inc.

Starting With The New Decade On A Diligent Note In The E Prescribing Market? https://www.persistencemarketresearch.co/methodology/3087

E-Prescribing systems are used in various applications including preparation of complete medication list, data security checks, complete information of formulary and patient historical data. These advanced features of E-Prescribing are also supporting in growth of E-Prescribing market. Additionally, improved healthcare infrastructure has increased the demand for E-Prescribing system.

Moreover, implementation of electronic healthcare records with E-Prescribing system holds immense potential for the growth of E-Prescribing market. E-Prescribing market is expected to grow a CAGR of about 23.5% during 2013-2019.

However, high cost of E-Prescribing system and lack of patient privacy and security impede growth of E-Prescribing market. Moreover, lack of high-speed broadband facilities and IT professionals in rural areas are also some of the key restraints for the E-Prescribing market.

Europe holds the largest share in E-Prescribing market. Many eHealth projects in Europe are playing a vital role in the adoption of E-Prescribing system such as European Patient Smart Open Services (epSOS) and Schleswig-Holstein Health Initiative.

How About Obtaining Insights About The Region To Enter Concerning The E Prescribing Market? Press The “Purchase Now” Button To Have Our E Prescribing Market Report! https://www.persistencemarketresearch.com/checkout/3087

However, North America is the fastest growing region in the E-Prescribing market. Increased adoption of E-Prescribing system and improved healthcare infrastructure are major drivers for E-Prescribing market in North America. Moreover, several government initiatives are also promoting the usage of E-Prescribing system such as Health Information Technology for Economic and Clinical Health (HITECH) Act and National Council for Prescription Drugs Program.

In Asia, usage of E-Prescribing system is increasing due to medical infrastructure development and government initiative programs. Growing medical infrastructure has led to improvement in primary healthcare services, village clinics and urban healthcare centers through the adoption of healthcare IT technologies.

About Us: -

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers 'experience by acting as the “missing” link between “customer relationships” and “business outcomes'. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address - 305 Broadway, 7th Floor New York City,
NY 10007 United States
U.S. Ph. - + 1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales  - sales@persistencemarketresearch.com
Website  - https://www.persistencemarketresearch.com

]]>